How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Monday - Friday, 6:00 - 9:00 AM ET Favor Micron as cash flows will make up a large part of the market cap, says Alger's Ankur Crawford United States Monday - Friday 6a ET Europe Monday - Friday 13:00 ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results